Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Avantis International Small Cap Value ETF (AVDV) vs Medpace Holdings Inc (MEDP) Price & Performance

Avantis International Small Cap Value ETFTrade
Medpace Holdings IncTrade

Price performance (Past 24H)

Key statistics

Avantis International Small Cap Value ETF vs Medpace Holdings Inc — how do they compare? Avantis International Small Cap Value ETF trades at $104.6, while Medpace Holdings Inc trades at $535.22 (market cap $15.31B). Which is the better fit depends on your goals.

AVDVMEDP
Sector
Sector/ThematicTechnology
52-Week High
$110.40$620.59
52-Week Low
$80.02$308.88
Market Cap
$15.31B
Enterprise Value
$14.78B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Avantis International Small Cap Value ETF

AVDV trades at $103.10, down 1.06% with a bearish technical signal from moving averages. Recent news highlights strong 2026 performance with international small-cap value strategies delivering 35% gains while paying dividends. The fund's commodity exposure has cooled after driving outperformance, shifting the forward setup.

The outlook remains mixed with technical indicators signaling caution but positive sentiment around international small-cap value diversification. Key risks include commodity volatility and regional economic exposure, while institutional interest grows with Farther Finance increasing holdings by 165.8% in Q4 2025.

Medpace Holdings Inc

MEDP trades at $530.19, down 1.49% on the day, with a bullish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q2 2026 results expected on July 22, 2026. Fundamentals show robust profitability with a 17.19% net income margin and 77.25% ROE, though valuation ratios like P/E of 33.74 are elevated. Recent news highlights volatility and a class action lawsuit filed in June 2026.

Outlook is mixed; earnings momentum and high profitability support upside, but high valuation and legal overhang pose risks. Analyst consensus is cautious with a $497 price target below current levels, suggesting limited near-term gains. Investors should weigh strong operational performance against valuation concerns and litigation risks.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Avantis International Small Cap Value ETF

AVDV is an actively managed ETF that targets small-cap value companies in developed markets outside the United States. It uses a systematic, rules-based process to identify firms trading at low valuations with high profitability, aiming to capture the 'size' and 'value' premiums while maintaining broad diversification.

Read more on AVDV

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP